
Zacks Investment Ideas feature highlights: Coinbase Global, Galaxy Digital, BlackRock, IBIT, Robinhood, Interactive Brokers and Alphabet
Chicago, IL – July 15, 2025– Today, Zacks Investment Ideas feature highlights Coinbase Global COIN, Galaxy Digital GLXY, BlackRock's BLK, iShares Bitcoin ETF IBIT, Robinhood HOOD, Interactive Brokers IBKR and Alphabet's GOOGL.
Bitcoin's Unstoppable Rise: 5 Reasons $150k Is Next
"The hard-to-believe 'Great Paradox' in the stock market is: What seems too high and risky to the majority usually goes higher eventually, and what seems low and cheap usually goes lower." ~William J. O'Neil
Bitcoin Is the Best Performing Asset
Bitcoin was once called a "gambling token" and "rat poison squared" by legendary investor Warren Buffett, arguably the best investor of his time. However, by now, it has become impossible for Wall Street to deny the once obscure and first-of-its-kind cryptocurrency.
A decade ago, Bitcoin traded at $286. Today, Bitcoin hit another all-time high of $123,000, marking a 430x increase over the past ten years and accruing an eye-popping 83% annualized return, far surpassing the next best asset class. Now, Bitcoin is one of the largest asset classes in the world. Below are five reasons the momentum is likely to continue into 2026, including:
1. Bitcoin: Digital Gold
What differentiates Bitcoin from fiat currency and any other cryptocurrency is its scarcity and role as a store of value. Unlike fiat currency, which can be printed by central bankers out of thin air, there will only ever be 21 million Bitcoins in existence.
Why is this important? As global central banks around the world print trillions of dollars and borrow money, fiat currencies like the dollar continue to lose value. As a result, investors gravitate towards Bitcoin and metals to fight this phenomenon. With the US passing another massive spending bill recently, there is no end in sight to this troubling trend in fiat.
2. Bitcoin ETFs Provide Wider Access
Until recently, investors who wanted to buy Bitcoin had to have a separate crypto account through an exchange like Coinbase Global or Galaxy Digital. However,early last year, theUS Securities and Exchange Commission finally approved Bitcoin ETFs, allowing far more access to a larger group of investors.
The launch of Bitcoin ETFs like BlackRock's, iShares Bitcoin ETF underscores the success. IBIT was the most successful ETF launch in history and is already the 20 th largest ETF in the United States. In addition to the ETF approvals, traditional stock brokers like Robinhood and Interactive Brokers now offer a suite of crypto trading products.
3. Bitcoin Week Looms
This week has been dubbed 'Crypto Week' by the Republicans. DC is slated to vote on the 'GENIUS Act,' which will provide a regulatory framework around stablecoins like Circle Group's USDC token. 'The CLARITY Act' will also aim to establish a comprehensive regulatory framework for digital assets. Crypto companies have had to deal with regulatory ambiguity from regulators for years. With a clear regulatory framework, more institutional investors are likely to flock to the digital asset industry.
4. Lack of Hype Around Bitcoin
Though Bitcoin continues to print fresh all-time highs, you wouldn't know it by looking at Bitcoin interest on Alphabet's 'Google Trends.' Interest is at multi-year lows, presenting investors with a contrarian opportunity.
5. Bitcoin Fibs Suggest $150k Price Target
Market technicians use Fibonacci levels as a tool to identify potential price targets. The Bitcoin fibs suggest that a price target of $150k by early 2026 is realistic.
Bottom Line
As market technicians now eye a $150k price target, Bitcoin's ongoing momentum suggests that its remarkable growth story is far from over, reminding investors that true opportunity often lies where the majority hesitates.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BlackRock (BLK): Free Stock Analysis Report
Interactive Brokers Group, Inc. (IBKR): Free Stock Analysis Report
Alphabet Inc. (GOOGL): Free Stock Analysis Report
Coinbase Global, Inc. (COIN): Free Stock Analysis Report
Robinhood Markets, Inc. (HOOD): Free Stock Analysis Report
Galaxy Digital Inc. (GLXY): Free Stock Analysis Report
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
12 minutes ago
- Globe and Mail
VSTS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Vestis Corporation - August 8, 2025 Deadline
New York, New York--(Newsfile Corp. - July 22, 2025) - If you suffered a loss on your Vestis Corporation (NYSE: VSTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Vestis Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 2, 2024 and May 6, 2025. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Vestis' ability to grow its business; notably that Vestis would be unable to execute on planned strategic initiatives to drive purported improvements to the customer experience and its onboarding efforts in order to drive new customer growth, increased customer retention, and increased revenue from existing customers. On May 7, 2025, Vestis announced its financial results for the second quarter of fiscal 2025, withdrew its revenue and growth guidance for the full fiscal year 2025, and provided guidance for the third quarter of fiscal 2025 that fell significantly below market expectations. The Company attributed its poor results partially to "lost business in excess of new business," but primarily on "lower adds over stops, which is how we describe volume changes with our existing customers." The Company attributed its decision to pull full-year guidance and provide disappointing third quarter targets to the "increasingly uncertain macro environment." Following this news, the price of Vestis' common stock declined dramatically. From a closing market price of $8.71 per share on May 6, 2025, Vestis' stock price fell to $5.44 per share on May 7, 2025, a decline of about 37.54% in the span of just a single day. WHAT'S NEXT? If you suffered a loss in Vestis stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes. To view the source version of this press release, please visit


Globe and Mail
12 minutes ago
- Globe and Mail
ADM to Release Second Quarter Financial Results on Aug. 5, 2025
ADM (NYSE: ADM) will release financial results for the second quarter of 2025 before the market opens on Tuesday, Aug 5. A slide presentation will also be available for download. The company will host a webcast at 9 a.m. Central Time to discuss the results and provide a company update. To listen to the webcast or to download the slide presentation, go to A replay of the webcast will also be available for an extended period of time at About ADM ADM unlocks the power of nature to enrich the quality of life. We're an essential global agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. We're a premier human and animal nutrition provider, offering one of the industry's broadest portfolios of ingredients and solutions from nature. We're a trailblazer in health and well-being, with an industry-leading range of products for consumers looking for new ways to live healthier lives. We're a cutting-edge innovator, guiding the way to a future of new bio-based consumer and industrial solutions. And we're leading in business-driven sustainability efforts that support a strong agricultural sector, resilient supply chains, and a vast and growing bioeconomy. Around the globe, our expertise and innovation are meeting critical needs from harvest to home. Learn more at


Globe and Mail
12 minutes ago
- Globe and Mail
Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline
New York, New York--(Newsfile Corp. - July 22, 2025) - If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Rocket Pharmaceuticals, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RP-A501's safety and clinical trial protocol; notably, that Rocket knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Rocket's securities at artificially inflated prices. On May 27, 2025, Rocket announced that the FDA placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event (SAE), ultimately, death, while enrolled in the study following a substantive amendment to the protocol that the Company failed to disclose to investors at the time management made the revision. In fact, Rocket stated that, while the patient was dosed in May, the decision to amend the protocol was made "several months" earlier. Despite this, Rocket made no attempt to alert investors or the public to the change until after the SAE occurred. Following this news, the price of Rocket's common stock declined dramatically. From a closing market price of $6.27 per share on May 23, 2025, Rocket's stock price fell to $2.33 per share on May 27, 2025, a decline of about 37% in the span of just a single trading day. WHAT'S NEXT? If you suffered a loss in Rocket stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes. To view the source version of this press release, please visit